Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5604]
News [13558]
Articles [218]
Editorials [5]
Conferences [266]
elearning [17]

Randomized Phase II Study in Patients with HER2-Positive Breast Cancer

Dr Luca Gianni - Ospedale San Raffaele, Milan, Italy
Randomized Phase II Study in Patients with HER2-Positive Breast Cancer ( Dr Luca Gianni - Ospedale San Raffaele, Milan, Italy )
16 Dec 2011

Influence of age and BRCA status on contralateral breast cancer risk

Alexandra van den Broek - Netherlands Cancer Institute, Amsterdam
Influence of age and BRCA status on contralateral breast cancer risk ( Alexandra van den Broek - Netherlands Cancer Institute, Amsterdam )
16 Dec 2011

Novel agents and proteasome inhibitors in myeloma

Prof Michele Cavo - University of Bologna, Italy
Novel agents and proteasome inhibitors in myeloma ( Prof Michele Cavo - University of Bologna, Italy )
14 Dec 2011

Advances in peripheral T-cell lymphoma

Prof John Gribben – Barts and The London Trust, London and Prof Bertrand Coiffier - Hospices Civils de Lyon, France
Advances in peripheral T-cell lymphoma ( Prof John Gribben – Barts and The London Trust, London and Prof Bertrand Coiffier - Hospices Civils de Lyon, France )
14 Dec 2011

Final results of the phase 3 VISTA trial: bortezomib-melphalan-prednisone (VMP) vs melphalan-prednisone (MP) for multiple myeloma

Dr Maria-Victoria Mateos - University Hospital of Salamanca, Spain
Final results of the phase 3 VISTA trial: bortezomib-melphalan-prednisone (VMP) vs melphalan-prednisone (MP) for multiple myeloma ( Dr Maria-Victoria Mateos - University Hospital of Salamanca, Spain )
14 Dec 2011

Translational research and proteasome inhibitors in multiple myeloma

Prof Kenneth Anderson - Dana-Farber Cancer Institute, Boston, USA
Translational research and proteasome inhibitors in multiple myeloma ( Prof Kenneth Anderson - Dana-Farber Cancer Institute, Boston, USA )
14 Dec 2011

CLEOPATRA trial to evaluate the efficacy and safety of pertuzumab + trastuzumab + docetaxel

Prof Jose Baselga - Massachusetts General Hospital Cancer Center, Boston, MA
CLEOPATRA trial to evaluate the efficacy and safety of pertuzumab + trastuzumab + docetaxel ( Prof Jose Baselga - Massachusetts General Hospital Cancer Center, Boston, MA )
14 Dec 2011

Developments in proteasome inhibitors, transplant and myeloma research

Dr Keith Stewart - Mayo Clinic, Scottsdale Arizona, USA
Developments in proteasome inhibitors, transplant and myeloma research ( Dr Keith Stewart - Mayo Clinic, Scottsdale Arizona, USA )
14 Dec 2011

Cultural sensitivity in palliative care

Dr Deena Aljawi - King Faisai Specialist Hospital, Riyadh, Saudi Arabia
Cultural sensitivity in palliative care ( Dr Deena Aljawi - King Faisai Specialist Hospital, Riyadh, Saudi Arabia )
14 Dec 2011

Lenalidomide with melphalan + prednisone and lenalidomide maintenance for multiple myeloma

Prof Antonio Palumbo - University of Torino, Italy
Lenalidomide with melphalan + prednisone and lenalidomide maintenance for multiple myeloma ( Prof Antonio Palumbo - University of Torino, Italy )
13 Dec 2011

HIV treatment for African children

Prof Christina Stefan - Stellenbosch University, South Africa
HIV treatment for African children ( Prof Christina Stefan - Stellenbosch University, South Africa )
13 Dec 2011

The role of online education in African oncology nursing

Dr Deborah McLeod - Dalhousie University, Halifax, Canada
The role of online education in African oncology nursing ( Dr Deborah McLeod - Dalhousie University, Halifax, Canada )
13 Dec 2011

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation